Table 4.: Association Between Different HPV Genotypes and HIV in LBC Samples

Genotype Total HIV +ve HIV-ve P- Value
Frequency/% Frequency/% Frequency/%
High Risk
56 23/10.3% 15/65.2% 8/34.8% 0.203
52 20/8.9% 17/85.0% 3/15.0% 0.003
58 18/8.0% 15/83.3% 3/16.7% 0.009
16 15/6.7% 8/53.3% 7/46.7% 0.586
35 13/5.8% 7/53.8% 6/46.2% 0.583
53 12/9.9% 11/91.7% 1/8.3% 0.009
33 12/5.4% 6/50% 6/50% 0.599
59 10/8.3% 5/50% 5/50% 0.521
66 9/7.4% 7/77.8% 2/22.2% 0.058
39 9/7.4% 7/77.8% 2/22.2% 0.058
82 9/7.4% 6/66.7% 3/33.3% 0.243
68 6/5.0% 6/100% 0/0.0% 0.040
51 5/4.1% 2/40% 3.6 0.499
70 5/4.1% 5/100% 0/0.0% 0.068
45 4/1.8% 4/100% 0/0.0% 0.083
31 4/3.3% 3/75% 1/25% 0.414
18 3/1.3% 3/100% 0/0.0% 0.137
Low Risk
44/55 15/13.2% 14/93.3% 1/6.7% 0.002
42 8/6.6% 5/62.5% 3/37.55 0.966
43 6/5.0% 5/83.3% 1/16.7% 0.115
11 5/4.1% 2%/50% 2/50% 0.406
40 4/3.3% 3/75% 1/255 0.414
6 1/0.8% 1/100% 0/0.0% 0.616

Although HPV infection was generally more prevalent in HIV +ve than in HIV -ve patients, genotypes 52, 58, 53, 68 and 44/55 showed the most significant association with HIV (Significant p values shown in bold). Total sample number n= 224.